Moody’s affirms H. Lee Moffitt Cancer Center’s ‘A3’ rating

Moody’s Investors Service has affirmed the “A3” rating assigned to Tampa, Fla.-based H. Lee Moffitt Cancer Center’s bonds, affecting approximately $143 million of debt.

Advertisement

The rating affirmation is based on several factors, including Moffitt’s strong reputation for tertiary and quaternary services and its recently solid financial performance.

Offsetting these strengths are Moffitt’s modest balance sheet measures, which show room for improvement.

The outlook is stable, reflecting Moody’s expectation that Moffitt will continue to generate healthy margins.

More articles on healthcare finance:
For-profit hospital stock report: Week of Dec. 7-11
7 in 10 Kentucky residents don’t want to cut back Medicaid expansion
How fingerprint scans can help maximize hospital cash flow

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.